Outcome Measures
RECURRENCE, CHEMOTHERAPY EFFECTS, RECURRENT DISEASE
The primary outcome was residual or recurrent disease within 2 years from random assignment. This was chosen to maximize statistical power, as chemotherapy effects on recurrence are concentrated in this period.